Filtered By:
Vaccination: Influenza Vaccine

This page shows you your search results in order of date.

Order by Relevance | Date

Total 427 results found since Jan 2013.

Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study
CONCLUSION: Our study revealed that most side effects reported were mild in severity and self-limiting. Increasing the public's awareness of the nature of the vaccine's side effects would reduce the misinformation and improve the public's trust in vaccines. Larger studies to evaluate rare and serious adverse events and long-term side effects are needed, so people can have sufficient information and understanding before making an informed consent which is essential for vaccination.PMID:37544017 | PMC:PMC10405764 | DOI:10.1080/07853890.2023.2241351
Source: Annals of Medicine - August 6, 2023 Category: Internal Medicine Authors: Michel Najjar Sara Albuaini Mohammad Fadel Fatema Mohsen Data Collection Group Source Type: research

Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35  Months in South Korea
ConclusionThis active safety surveillance study confirms that QIV is well tolerated in children aged 6 –35 months in routine clinical practice in South Korea. There were no safety concerns observed in these young children.
Source: Infectious Diseases and Therapy - June 10, 2023 Category: Infectious Diseases Source Type: research

The Pandemic Didn ’ t Really Change How Americans Think About Sickness
Thomas McDade, a biological anthropologist at Northwestern University, still remembers an advertisement for cold medicine he saw in late 2019. The ad showed a visibly sick businessman walking through an airport, “and the message was, ‘You can solider through this. You can make it,'” McDade says. That message didn’t age well. Only a few months later, the virus that causes COVID-19 began spreading across the globe, prompting health officials to beg people to stay home no matter what—but especially if they felt sick. Suddenly, soldiering through an illness wasn’t seen as admirable, but irre...
Source: TIME: Health - May 15, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

A randomized, double-blind, non-inferiority trial comparing the immunogenicity and safety of two seasonal inactivated influenza vaccines in adults
CONCLUSION: This study demonstrated the non-inferiority of the immunogenicity of a single-dose of Instituto Butantan versus a single dose of the Sanofi Pasteur Seasonal Trivalent Influenza Vaccine in adults. Both vaccines were well tolerated and presented similar safety profiles.PMID:37121800 | DOI:10.1016/j.vaccine.2023.04.050
Source: Vaccine - April 30, 2023 Category: Allergy & Immunology Authors: Tazio Vanni Maria da Gra ça Salomão Juliana Yukari Kodaira Viscondi Patr ícia Emilia Braga Anderson da Silva Roberta de Oliveira Piorelli Joane do Prado Santos Vera L úcia Gattás Maria Beatriz Bastos Lucchesi Mayra Martho Moura de Oliveira Marcelo Ei Source Type: research

What Causes Parotitis?
Discussion The salivary glands are important for creating saliva which helps with taste, digestion, oral health, and speech. Salivary gland problems are not that common but can be painful, annoying or herald potential systemic diseases. The parotid gland is the largest salivary gland lying anterior to the ear within the cheek structures. There are 2 lobes (superficial and deep) and the facial nerve runs between them. The salivary duct opens adjacent to the upper second molar. Infections are the most common cause of parotitis with mumps being the most commonly associated infection especially in unimmunized patients. Patient...
Source: PediatricEducation.org - April 10, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Shoulder Pain Following Influenza Vaccine Administration: A Clinical Vignette
Am J Phys Med Rehabil. 2023 Mar 21. doi: 10.1097/PHM.0000000000002242. Online ahead of print.NO ABSTRACTPMID:37026846 | DOI:10.1097/PHM.0000000000002242
Source: Health Physics - April 7, 2023 Category: Physics Authors: Evan R Zeldin Deanna Boyette John W Norbury Source Type: research

COVID-19 (Omicron strain) hospital admissions from a virtual ward - who required further care?
CONCLUSIONS: Few patients required admission from the virtual ward in the setting of the Omicron variant (BA.1, BA.2) as a direct result of COVID-19 disease and virtual ward care. Shortness of breath and chest pain were the most common symptoms driving further clinical care.PMID:36991540 | PMC:PMC10040950 | DOI:10.1111/irv.13108
Source: Respiratory Care - March 30, 2023 Category: Respiratory Medicine Authors: Ian Mackay Megan France Duncan McAuley Sean Wing Mary Wheeldon Susan Britton Catherine Todd Alexandra Pitiris Leah Barrett-Beck Elizabeth Rushbrook Cameron Bennett Kate McCarthy Source Type: research

IJERPH, Vol. 20, Pages 5026: Impact of COVID-19 on the Health-Related Quality of Life of Patients during Infection and after Recovery in Saudi Arabia
This study evaluated the impact of COVID-19 and other factors on the health-related quality of life (HRQoL) of Saudi patients during infection and after recovery using the EQ-5D-5L and EQ-VAS instruments. An observational prospective study was conducted in November 2022, during which 389 COVID-19 patients were surveyed during their visit to a medical center. Two weeks after their recovery, they were contacted again to re-evaluate their HRQoL (192 patients either refused to participate or withdrew). The mean of the EQ-5D-5L index and EQ-VAS scores significantly increased from (0.69 ± 0.29 and 63.16 &p...
Source: International Journal of Environmental Research and Public Health - March 12, 2023 Category: Environmental Health Authors: Menyfah Q. Alanazi Waleed Abdelgawwad Thamer A. Almangour Fatma Mostafa Mona Almuheed Tags: Article Source Type: research

Late-Breaking Phase 3 A DUE Data Show Investigational Single Tablet Combination Therapy of Macitentan and Tadalafil Significantly Improves Pulmonary Hemodynamics versus Monotherapy in Patients with Pulmonary Arterial Hypertension (PAH)
RARITAN, NJ, March 6, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 3 A DUE study (NCT03904693), which showed an investigational once-daily, single tablet combination therapy, also known as fixed dose combination, of macitentan 10 mg and tadalafil 40 mg (M/T STCT), significantly improved pulmonary hemodynamics (blood flow through pulmonary blood vessels) versus macitentan and tadalafil monotherapies in pulmonary arterial hypertension (PAH) patients with World Health Organization (WHO) functional class (FC) II or III.[1] The data were presented today as a Late-...
Source: Johnson and Johnson - March 6, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

Myocarditis update from Sweden
BY ANISH KOKA The COVID19/vaccine myocarditis debate continues in large part because our public health institutions are grossly mischaracterizing the risks and benefits of vaccines to young people. A snapshot of what the establishment says as it relates to the particular area of concern: college vaccine mandates: Dr. Arthur Reingold, an epidemiology professor at UC-Berkeley, notes that UC also requires immunizations for measles and chickenpox, and people still are dying from COVID at rates that exceed those for influenza. As of Feb. 1, there were more than 400 COVID deaths a day across the U.S. “The arg...
Source: The Health Care Blog - February 27, 2023 Category: Consumer Health News Authors: Ryan Bose-Roy Tags: Medical Practice Anish Koka covid19 myocarditis Sweden Source Type: blogs

Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial
CONCLUSIONS: Immune responses after coadministration of PCV20 and QIV were noninferior to separate administration of either vaccine. The PCV20 safety profile was similar when given together with or after QIV. These findings support PCV20 and QIV coadministration.TRIAL REGISTRATION: ClinicalTrials.gov, NCT04526574.PMID:36828719 | DOI:10.1016/j.vaccine.2022.11.046
Source: Vaccine - February 24, 2023 Category: Allergy & Immunology Authors: Kevin Cannon Jose F Cardona Kari Yacisin Allison Thompson Todd J Belanger Dung-Yang Lee Yahong Peng Lisa Moyer John Ginis William C Gruber Daniel A Scott Wendy Watson Source Type: research